.AstraZeneca managers state they are "not stressed" that the breakdown of tozorakimab in a phase 2 c...
.Invite to today's Chutes & Ladders, our summary of substantial management hirings, shootings and...
.After exposing strategies to reach the united state public markets less than a month back, Zenas Bi...
.Psyence Biomedical is paying for $500,000 in allotments to obtain fellow psilocybin-based biotech C...
.Five months after validating Power Therapeutics' Pivya as the initial new therapy for easy urinary ...
.Eli Lilly has vaulted right into an AI-enabled medication discovery offer, partnering with RNA expe...
.Lykos chief executive officer as well as creator Amy Emerson is actually quiting, with chief workin...
.Novartis levels a brand-new outpost in its own collaboration with Voyager Therapeutics, paying $15 ...
.On the heels of an FDA rejection for its main competing Novo Nordisk, Eli Lilly is actually picking...
.Simply a couple of months after dosing the 1st individual in a stage 2 trial for recently detected ...